Connexins: Sensors and regulators of cell cycling

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1815, Issue 1, 2011, Pages 13-25

  Vinken, Mathieu ^a   Decrock, Elke ^b   De Vuyst, Elke ^b   Ponsaerts, Raf ^c   D'hondt, Catheleyne ^c   Bultynck, Geert ^c   Ceelen, Liesbeth ^a   Vanhaecke, Tamara ^a   Leybaert, Luc ^b   Rogiers, Vera ^a  

^a FACULTY OF MEDICINE AND PHARMACY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Cell cycle; Connexin; Gap junction; Hemichannel; Pannexin

Indexed keywords

GAP JUNCTION PROTEIN; MEMBRANE PROTEIN; PANNEXIN; UNCLASSIFIED DRUG;

CELL COMMUNICATION; CELL CYCLE; CELL CYCLE REGULATION; CELL GROWTH; CELL PROLIFERATION; GAP JUNCTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL CYCLE; CELL PROLIFERATION; CONNEXINS; GENE EXPRESSION REGULATION; HUMANS; SIGNAL TRANSDUCTION;

EID: 78650582972     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbcan.2010.08.004     Document Type: Review

References (295)

1. Malumbres M., Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 2009, 9:153-166.
2. Fussenegger M., Bailey J.E. Molecular regulation of cell-cycle progression and apoptosis in mammalian cells: implications for biotechnology. Biotechnol. Prog. 1998, 14:807-833.
3. Suryadinata R., Sadowski M., Sarcevic B. Control of cell cycle progression by phosphorylation of cyclin-dependent kinase (CDK) substrates. Biosci. Rep. 2010, 30:243-255.
4. van den Heuvel S. Cell-cycle regulation. WormBook 2005, 1-16.
5. Meloche S., Pouyssegur J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 2007, 26:3227-3239.
6. Vinken M., De Rop E., Decrock E., De Vuyst E., Leybaert L., Vanhaecke T., Rogiers V. Epigenetic regulation of gap junctional intercellular communication: more than a way to keep cells quiet?. Biochim. Biophys. Acta 2009, 1795:53-61.
7. Vinken M., Doktorova T., Decrock E., Leybaert L., Vanhaecke T., Rogiers V. Gap junctional intercellular communication as a target for liver toxicity and carcinogenicity. Crit. Rev. Biochem. Mol. Biol. 2009, 44:201-222.
8. Vinken M., Henkens T., De Rop E., Fraczek J., Vanhaecke T., Rogiers V. Biology and pathobiology of gap junctional channels in hepatocytes. Hepatology 2008, 47:1077-1088.
9. Vinken M., Papeleu P., Snykers S., De Rop E., Henkens T., Chipman J.K., Rogiers V., Vanhaecke T. Involvement of cell junctions in hepatocyte culture functionality. Crit. Rev. Toxicol. 2006, 36:299-318.
10. Vinken M., Vanhaecke T., Papeleu P., Snykers S., Henkens T., Rogiers V. Connexins and their channels in cell growth and cell death. Cell. Signal. 2006, 18:592-600.
11. Dbouk H.A., Mroue R.M., El-Sabban M.E., Talhouk R.S. Connexins: a myriad of functions extending beyond assembly of gap junction channels. Cell. Commun. Signal 2009, 7:4.
12. Goodenough D.A., Paul D.L. Gap junctions. Cold Spring Harbor Perspect. Biol. 2009, 1:a002576.
13. Rackauskas M., Neverauskas V., Skeberdis V.A. Diversity and properties of connexin gap junction channels. Medicina 2010, 46:1-12.
14. Laird D.W. The gap junction proteome and its relationship to disease. Trends Cell Biol. 2010, 20:92-101.
15. Alexander D.B., Goldberg G.S. Transfer of biologically important molecules between cells through gap junction channels. Curr. Med. Chem. 2003, 10:2045-2058.
16. Decrock E., Vinken M., De Vuyst E., Krysko D.V., D'Herde K., Vanhaecke T., Vandenabeele P., Rogiers V., Leybaert L. Connexin-related signaling in cell death: to live or let die?. Cell Death Differ. 2009, 16:524-536.
17. Cottrell G.T., Burt J.M. Functional consequences of heterogeneous gap junction channel formation and its influence in health and disease. Biochim. Biophys. Acta 2005, 1711:126-141.
18. Goldberg G.S., Moreno A.P., Lampe P.D. Gap junctions between cells expressing connexin 43 or 32 show inverse permselectivity to adenosine and ATP. J. Biol. Chem. 2002, 277:36725-36730.
19. D'Hondt C., Ponsaerts R., De Smedt H., Bultynck G., Himpens B. Pannexins, distant relatives of the connexin family with specific cellular functions?. Bioessays 2009, 31:953-974.
20. Evans W.H., De Vuyst E., Leybaert L. The gap junction cellular internet: connexin hemichannels enter the signalling limelight. Biochem. J. 2006, 397:1-14.
21. Schalper K.A., Palacios-Prado N., Orellana J.A., Saez J.C. Currently used methods for identification and characterization of hemichannels. Cell Commun. Adhes. 2008, 15:207-218.
22. Moreno A.P., Lau A.F. Gap junction channel gating modulated through protein phosphorylation. Prog. Biophys. Mol. Biol. 2007, 94:107-119.
23. Solan J.L., Lampe P.D. Connexin43 phosphorylation: structural changes and biological effects. Biochem. J. 2009, 419:261-272.
24. Sohl G., Willecke K. Gap junctions and the connexin protein family. Cardiovasc. Res. 2004, 62:228-232.
25. Oyamada M., Oyamada Y., Takamatsu T. Regulation of connexin expression. Biochim. Biophys. Acta 2005, 1719:6-23.
26. Anderson C., Catoe H., Werner R. MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Res. 2006, 34:5863-5871.
27. Callis T.E., Pandya K., Seok H.Y., Tang R.H., Tatsuguchi M., Huang Z.P., Chen J.F., Deng Z., Gunn B., Shumate J., Willis M.S., Selzman C.H., Wang D.Z. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J. Clin. Invest. 2009, 119:2772-2786.
28. Inose H., Ochi H., Kimura A., Fujita K., Xu R., Sato S., Iwasaki M., Sunamura S., Takeuchi Y., Fukumoto S., Saito K., Nakamura T., Siomi H., Ito H., Arai Y., Shinomiya K.I., Takeda S. A microRNA regulatory mechanism of osteoblast differentiation. Proc. Natl Acad. Sci. USA 2009, 106:20794-20799.
29. Kim H.K., Lee Y.S., Sivaprasad U., Malhotra A., Dutta A. Muscle-specific microRNA miR-206 promotes muscle differentiation. J. Cell Biol. 2006, 174:677-687.
30. Lu Y., Zhang Y., Shan H., Pan Z., Li X., Li B., Xu C., Zhang B., Zhang F., Dong D., Song W., Qiao G., Yang B. MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection. Cardiovasc. Res. 2009, 84:434-441.
31. Yang B., Lin H., Xiao J., Lu Y., Luo X., Li B., Zhang Y., Xu C., Bai Y., Wang H., Chen G., Wang Z. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat. Med. 2007, 13:486-491.
32. Goodall H., Maro B. Major loss of junctional coupling during mitosis in early mouse embryos. J. Cell Biol. 1986, 102:568-575.
33. Lampe P.D., Kurata W.E., Warn-Cramer B.J., Lau A.F. Formation of a distinct connexin43 phosphoisoform in mitotic cells is dependent upon p34cdc2 kinase. J. Cell Sci. 1998, 111:833-841.
34. Stein L.S., Boonstra J., Burghardt R.C. Reduced cell-cell communication between mitotic and nonmitotic coupled cells. Exp. Cell Res. 1992, 198:1-7.
35. Su J.W., Tertoolen L.G., de Laat S.W., Hage W.J., Durston A.J. Intercellular communication is cell cycle modulated during early Xenopus laevis development. J. Cell Biol. 1990, 110:115-121.
36. Xie H., Laird D.W., Chang T.H., Hu V.W. A mitosis-specific phosphorylation of the gap junction protein connexin43 in human vascular cells: biochemical characterization and localization. J. Cell Biol. 1997, 137:203-210.
37. O'Lague P., Dalen H., Rubin H., Tobias C. Electrical coupling: low resistance junctions between mitotic and interphase fibroblasts in tissue culture. Science 1970, 170:464-466.
38. Michalopoulos G.K., DeFrances M. Liver regeneration. Adv. Biochem. Eng. Biotechnol. 2005, 93:101-134.
39. Taub R. Liver regeneration: from myth to mechanism. Nat. Rev. Mol. Cell Biol. 2004, 5:836-847.
40. Dermietzel R., Yancey S.B., Traub O., Willecke K., Revel J.P. Major loss of the 28-kD protein of gap junction in proliferating hepatocytes. J. Cell Biol. 1987, 105:1925-1934.
41. Fladmark K.E., Gjertsen B.T., Molven A., Mellgren G., Vintermyr O.K., Doskeland S.O. Gap junctions and growth control in liver regeneration and in isolated rat hepatocytes. Hepatology 1997, 25:847-855.
42. Kojima T., Yamamoto T., Lan M., Murata M., Takano K., Go M., Ichimiya S., Chiba H., Sawada N. Inhibition of MAP kinase activity moderates changes in expression and function of Cx32 but not claudin-1 during DNA synthesis in primary cultures of rat hepatocytes. Med. Electron Microsc. 2004, 37:101-113.
43. Kojima T., Yamamoto T., Murata M., Lan M., Takano K., Go M., Ichimiya S., Chiba H., Sawada N. Role of the p38 MAP-kinase signaling pathway for Cx32 and claudin-1 in the rat liver. Cell Commun. Adhes. 2003, 10:437-443.
44. Yamamoto T., Kojima T., Murata M., Takano K., Go M., Hatakeyama N., Chiba H., Sawada N. p38 MAP-kinase regulates function of gap and tight junctions during regeneration of rat hepatocytes. J. Hepatol. 2005, 42:707-718.
45. Kren B.T., Kumar N.M., Wang S.Q., Gilula N.B., Steer C.J. Differential regulation of multiple gap junction transcripts and proteins during rat liver regeneration. J. Cell Biol. 1993, 123:707-718.
46. Meyer D.J., Yancey S.B., Revel J.P. Intercellular communication in normal and regenerating rat liver: a quantitative analysis. J. Cell Biol. 1981, 91:505-523.
47. Sugiyama Y., Ohta H. Changes in density and distribution of gap junctions after partial hepatectomy: immunohistochemical and morphometric studies. Arch. Histol. Cytol. 1990, 53:71-80.
48. Temme A., Ott T., Dombrowski F., Willecke K. The extent of synchronous initiation and termination of DNA synthesis in regenerating mouse liver is dependent on connexin32 expressing gap junctions. J. Hepatol. 2000, 32:627-635.
49. Yee A.G., Revel J.P. Loss and reappearance of gap junctions in regenerating liver. J. Cell Biol. 1978, 78:554-564.
50. Miyashita T., Takeda A., Iwai M., Shimazu T. Single administration of hepatotoxic chemicals transiently decreases the gap-junction-protein levels of connexin 32 in rat liver. Eur. J. Biochem. 1991, 196:37-42.
51. Traub O., Druge P.M., Willecke K. Degradation and resynthesis of gap junction protein in plasma membranes of regenerating liver after partial hepatectomy or cholestasis. Proc. Natl Acad. Sci. USA 1983, 80:755-759.
52. Li H., Chen X., Zhang F., Ma J., Xu C. Expression patterns of the cell junction-associated genes during rat liver regeneration. J. Genet. Genomics 2007, 34:892-908.
53. Koenig S., Krause P., Drabent B., Schaeffner I., Christ B., Schwartz P., Unthan-Fechner K., Probst I. The expression of mesenchymal, neural and haematopoietic stem cell markers in adult hepatocytes proliferating in vitro. J. Hepatol. 2006, 44:1115-1124.
54. Kojima T., Yamamoto M., Mochizuki C., Mitaka T., Sawada N., Mochizuki Y. Different changes in expression and function of connexin 26 and connexin 32 during DNA synthesis and redifferentiation in primary rat hepatocytes using a DMSO culture system. Hepatology 1997, 26:585-597.
55. Trovato-Salinaro A., Belluardo N., Frinchi M., von Maltzahn J., Willecke K., Condorelli D.F., Mudo G. Regulation of connexin gene expression during skeletal muscle regeneration in the adult rat. Am. J. Physiol. Cell Physiol. 2009, 296:C593-C606.
56. Gorbe A., Becker D.L., Dux L., Krenacs L., Krenacs T. In differentiating prefusion myoblasts connexin43 gap junction coupling is upregulated before myoblast alignment then reduced in post-mitotic cells. Histochem. Cell Biol. 2006, 125:705-716.
57. Gorbe A., Becker D.L., Dux L., Stelkovics E., Krenacs L., Bagdi E., Krenacs T. Transient upregulation of connexin43 gap junctions and synchronized cell cycle control precede myoblast fusion in regenerating skeletal muscle in vivo. Histochem. Cell Biol. 2005, 123:573-583.
58. Gordon R.E., Lane B.P., Marin M. Regeneration of rat tracheal epithelium: changes in gap junctions during specific phases of the cell cycle. Exp. Lung Res. 1982, 3:47-56.
59. Lee S.W., Tomasetto C., Paul D., Keyomarsi K., Sager R. Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumor cell lines. J. Cell Biol. 1992, 118:1213-1221.
60. Bittman K., Owens D.F., Kriegstein A.R., LoTurco J.J. Cell coupling and uncoupling in the ventricular zone of developing neocortex. J. Neurosci. 1997, 17:7037-7044.
61. Bittman K.S., LoTurco J.J. Differential regulation of connexin 26 and 43 in murine neocortical precursors. Cereb. Cortex 1999, 9:188-195.
62. Wilson M.R., Close T.W., Trosko J.E. Cell population dynamics (apoptosis, mitosis, and cell-cell communication) during disruption of homeostasis. Exp. Cell Res. 2000, 254:257-268.
63. Cheng A., Tang H., Cai J., Zhu M., Zhang X., Rao M., Mattson M.P. Gap junctional communication is required to maintain mouse cortical neural progenitor cells in a proliferative state. Dev. Biol. 2004, 272:203-216.
64. Haupt C., Witte O.W., Frahm C. Up-regulation of Connexin43 in the glial scar following photothrombotic ischemic injury. Mol. Cell. Neurosci. 2007, 35:89-99.
65. Lemaitre G., Sivan V., Lamartine J., Cosset J.M., Cavelier-Balloy B., Salomon D., Waksman G., Martin M.T. Connexin 30, a new marker of hyperproliferative epidermis. Br. J. Dermatol. 2006, 155:844-846.
66. Matsushita T., Rama A., Charolidi N., Dupont E., Severs N.J. Relationship of connexin43 expression to phenotypic modulation in cultured human aortic smooth muscle cells. Eur. J. Cell Biol. 2007, 86:617-628.
67. Shakespeare T.I., Sellitto C., Li L., Rubinos C., Gong X., Srinivas M., White T.W. Interaction between Connexin50 and mitogen-activated protein kinase signaling in lens homeostasis. Mol. Biol. Cell 2009, 20:2582-2592.
68. White T.W., Gao Y., Li L., Sellitto C., Srinivas M. Optimal lens epithelial cell proliferation is dependent on the connexin isoform providing gap junctional coupling. Invest. Ophthalmol Vis Sci. 2007, 48:5630-5637.
69. Edwards G.O., Jondhale S., Chen T., Chipman J.K. A quantitative inverse relationship between connexin32 expression and cell proliferation in a rat hepatoma cell line. Toxicology 2008, 253:46-52.
70. Lu F., Gao J., Ogawa R., Hyakusoku H. Variations in gap junctional intercellular communication and connexin expression in fibroblasts derived from keloid and hypertrophic scars. Plast. Reconstr. Surg. 2007, 119:844-851.
71. Miragall F., Albiez P., Bartels H., de Vries U., Dermietzel R. Expression of the gap junction protein connexin43 in the subependymal layer and the rostral migratory stream of the mouse: evidence for an inverse correlation between intensity of connexin43 expression and cell proliferation activity. Cell Tissue Res. 1997, 287:243-253.
72. Saito T., Tanaka R., Wataba K., Kudo R., Yamasaki H. Overexpression of estrogen receptor-alpha gene suppresses gap junctional intercellular communication in endometrial carcinoma cells. Oncogene 2004, 23:1109-1116.
73. Shiba Y., Sasaki Y., Kanno Y. Inhibition of gap-junctional intercellular communication and enhanced binding of fibronectin-coated latex beads by stimulation of DNA synthesis in quiescent 3T3-L1 cells. J. Cell. Physiol. 1990, 145:268-273.
74. Trovato-Salinaro A., Trovato-Salinaro E., Failla M., Mastruzzo C., Tomaselli V., Gili E., Crimi N., Condorelli D.F., Vancheri C. Altered intercellular communication in lung fibroblast cultures from patients with idiopathic pulmonary fibrosis. Respir. Res. 2006, 7:122.
75. Edry I., Sela-Abramovich S., Dekel N. Meiotic arrest of oocytes depends on cell-to-cell communication in the ovarian follicle. Mol. Cell. Endocrinol. 2006, 252:102-106.
76. Sun Q.Y., Miao Y.L., Schatten H. Towards a new understanding on the regulation of mammalian oocyte meiosis resumption. Cell Cycle 2009, 8:2741-2747.
77. Kim E.K., Choi E.J. Pathological roles of MAPK signaling pathways in human diseases. Biochim. Biophys. Acta 2010, 1802:396-405.
78. Krishna M., Narang H. The complexity of mitogen-activated protein kinases (MAPKs) made simple. Cell. Mol. Life Sci. 2008, 65:3525-3544.
79. Carystinos G.D., Kandouz M., Alaoui-Jamali M.A., Batist G. Unexpected induction of the human connexin 43 promoter by the ras signaling pathway is mediated by a novel putative promoter sequence. Mol. Pharmacol. 2003, 63:821-831.
80. Jia G., Cheng G., Gangahar D.M., Agrawal D.K. Involvement of connexin 43 in angiotensin II-induced migration and proliferation of saphenous vein smooth muscle cells via the MAPK-AP-1 signaling pathway. J. Mol. Cell. Cardiol. 2008, 44:882-890.
81. Jia G., Mitra A.K., Cheng G., Gangahar D.M., Agrawal D.K. Angiotensin II and IGF-1 regulate connexin43 expression via ERK and p38 signaling pathways in vascular smooth muscle cells of coronary artery bypass conduits. J. Surg. Res. 2007, 142:137-142.
82. Ko J.A., Yanai R., Morishige N., Takezawa T., Nishida T. Upregulation of connexin43 expression in corneal fibroblasts by corneal epithelial cells. Invest. Ophthalmol Vis Sci. 2009, 50:2054-2060.
83. Salameh A., Krautblatter S., Baessler S., Karl S., Rojas Gomez D., Dhein S., Pfeiffer D. Signal transduction and transcriptional control of cardiac connexin43 up-regulation after alpha 1-adrenoceptor stimulation. J. Pharmacol. Exp. Ther. 2008, 326:315-322.
84. Nadarajah B., Makarenkova H., Becker D.L., Evans W.H., Parnavelas J.G. Basic FGF increases communication between cells of the developing neocortex. J. Neurosci. 1998, 18:7881-7890.
85. Tacheau C., Fontaine J., Loy J., Mauviel A., Verrecchia F. TGF-beta induces connexin43 gene expression in normal murine mammary gland epithelial cells via activation of p38 and PI3K/AKT signaling pathways. J. Cell. Physiol. 2008, 217:759-768.
86. Granot I., Dekel N. Developmental expression and regulation of the gap junction protein and transcript in rat ovaries. Mol. Reprod. Dev. 1997, 47:231-239.
87. Oviedo-Orta E., Perreau M., Evans W.H., Potolicchio I. Control of the proliferation of activated CD4+ T cells by connexins. J. Leukoc. Biol. 2010, 88:79-86.
88. Koo S.K., Kim D.Y., Park S.D., Kang K.W., Joe C.O. PKC phosphorylation disrupts gap junctional communication at G0/S phase in clone 9 cells. Mol. Cell. Biochem. 1997, 167:41-49.
89. Dang X., Jeyaraman M., Kardami E. Regulation of connexin-43-mediated growth inhibition by a phosphorylatable amino-acid is independent of gap junction-forming ability. Mol. Cell. Biochem. 2006, 289:201-207.
90. Kardami E., Banerji S., Doble B.W., Dang X., Fandrich R.R., Jin Y., Cattini P.A. PKC-dependent phosphorylation may regulate the ability of connexin43 to inhibit DNA synthesis. Cell Commun. Adhes. 2003, 10:293-297.
91. Solan J.L., Fry M.D., TenBroek E.M., Lampe P.D. Connexin43 phosphorylation at S368 is acute during S and G2/M and in response to protein kinase C activation. J. Cell Sci. 2003, 116:2203-2211.
92. Kanemitsu M.Y., Jiang W., Eckhart W. Cdc2-mediated phosphorylation of the gap junction protein, connexin43, during mitosis. Cell Growth Differ. 1998, 9:13-21.
93. Melchheier I., von Montfort C., Stuhlmann D., Sies H., Klotz L.O. Quinone-induced Cdc25A inhibition causes ERK-dependent connexin phosphorylation. Biochem. Biophys. Res. Commun. 2005, 327:1016-1023.
94. Norris R.P., Freudzon M., Mehlmann L.M., Cowan A.E., Simon A.M., Paul D.L., Lampe P.D., Jaffe L.A. Luteinizing hormone causes MAP kinase-dependent phosphorylation and closure of connexin 43 gap junctions in mouse ovarian follicles: one of two paths to meiotic resumption. Development 2008, 135:3229-3238.
95. Sela-Abramovich S., Chorev E., Galiani D., Dekel N. Mitogen-activated protein kinase mediates luteinizing hormone-induced breakdown of communication and oocyte maturation in rat ovarian follicles. Endocrinology 2005, 146:1236-1244.
96. Abdelmohsen K., Gerber P.A., von Montfort C., Sies H., Klotz L.O. Epidermal growth factor receptor is a common mediator of quinone-induced signaling leading to phosphorylation of connexin-43: role of glutathione and tyrosine phosphatases. J. Biol. Chem. 2003, 278:38360-38367.
97. Cameron S.J., Malik S., Akaike M., Lerner-Marmarosh N., Yan C., Lee J.D., Abe J., Yang J. Regulation of epidermal growth factor-induced connexin 43 gap junction communication by big mitogen-activated protein kinase1/ERK5 but not ERK1/2 kinase activation. J. Biol. Chem. 2003, 278:18682-18688.
98. Cottrell G.T., Lin R., Warn-Cramer B.J., Lau A.F., Burt J.M. Mechanism of v-Src- and mitogen-activated protein kinase-induced reduction of gap junction communication. Am. J. Physiol. Cell Physiol. 2003, 284:C511-C520.
99. Hossain M.Z., Ao P., Boynton A.L. Platelet-derived growth factor-induced disruption of gap junctional communication and phosphorylation of connexin43 involves protein kinase C and mitogen-activated protein kinase. J. Cell. Physiol. 1998, 176:332-341.
100. Hossain M.Z., Jagdale A.B., Ao P., Kazlauskas A., Boynton A.L. Disruption of gap junctional communication by the platelet-derived growth factor is mediated via multiple signaling pathways. J. Biol. Chem. 1999, 274:10489-10496.
101. Klotz L.O., Patak P., Ale-Agha N., Buchczyk D.P., Abdelmohsen K., Gerber P.A., von Montfort C., Sies H. 2-Methyl-1,4-naphthoquinone, vitamin K(3), decreases gap-junctional intercellular communication via activation of the epidermal growth factor receptor/extracellular signal-regulated kinase cascade. Cancer Res. 2002, 62:4922-4928.
102. Malone P., Miao H., Parker A., Juarez S., Hernandez M.R. Pressure induces loss of gap junction communication and redistribution of connexin 43 in astrocytes. Glia 2007, 55:1085-1098.
103. Mograbi B., Corcelle E., Defamie N., Samson M., Nebout M., Segretain D., Fenichel P., Pointis G. Aberrant Connexin 43 endocytosis by the carcinogen lindane involves activation of the ERK/mitogen-activated protein kinase pathway. Carcinogenesis 2003, 24:1415-1423.
104. Park J.H., Lee M.Y., Heo J.S., Han H.J. A potential role of connexin 43 in epidermal growth factor-induced proliferation of mouse embryonic stem cells: involvement of Ca2+/PKC, p44/42 and p38 MAPKs pathways. Cell Prolif. 2008, 41:786-802.
105. Kim M.O., Lee Y.J., Han H.J. Involvement of Cx43 phosphorylation in 5'-N-ethylcarboxamide-induced migration and proliferation of mouse embryonic stem cells. J. Cell. Physiol. 2010, 224:187-194.
106. De Vuyst E., Decrock E., De Bock M., Yamasaki H., Naus C.C., Evans W.H., Leybaert L. Connexin hemichannels and gap junction channels are differentially influenced by lipopolysaccharide and basic fibroblast growth factor. Mol. Biol. Cell 2007, 18:34-46.
107. Retamal M.A., Froger N., Palacios-Prado N., Ezan P., Saez P.J., Saez J.C., Giaume C. Cx43 hemichannels and gap junction channels in astrocytes are regulated oppositely by proinflammatory cytokines released from activated microglia. J. Neurosci. 2007, 27:13781-13792.
108. Schalper K.A., Palacios-Prado N., Retamal M.A., Shoji K.F., Martinez A.D., Saez J.C. Connexin hemichannel composition determines the FGF-1-induced membrane permeability and free [Ca2+]i responses. Mol. Biol. Cell 2008, 19:3501-3513.
109. Muramatsu A., Iwai M., Morikawa T., Tanaka S., Mori T., Harada Y., Okanoue T. Influence of transfection with connexin 26 gene on malignant potential of human hepatoma cells. Carcinogenesis 2002, 23:351-358.
110. Nakano Y., Oyamada M., Dai P., Nakagami T., Kinoshita S., Takamatsu T. Connexin43 knockdown accelerates wound healing but inhibits mesenchymal transition after corneal endothelial injury in vivo. Invest. Ophthalmol Vis Sci. 2008, 49:93-104.
111. Naus C.C., Elisevich K., Zhu D., Belliveau D.J., Del Maestro R.F. In vivo growth of C6 glioma cells transfected with connexin43 cDNA. Cancer Res. 1992, 52:4208-4213.
112. Olbina G., Eckhart W. Mutations in the second extracellular region of connexin 43 prevent localization to the plasma membrane, but do not affect its ability to suppress cell growth. Mol. Cancer Res. 2003, 1:690-700.
113. Omori Y., Duflot-Dancer A., Mesnil M., Yamasaki H. Role of connexin (gap junction) genes in cell growth control: approach with site-directed mutagenesis and dominant-negative effects. Toxicol. Lett. 1998, 96-97:105-110.
114. Omori Y., Yamasaki H. Mutated connexin43 proteins inhibit rat glioma cell growth suppression mediated by wild-type connexin43 in a dominant-negative manner. Int. J. Cancer 1998, 78:446-453.
115. Omori Y., Yamasaki H. Gap junction proteins connexin32 and connexin43 partially acquire growth-suppressive function in HeLa cells by deletion of their C-terminal tails. Carcinogenesis 1999, 20:1913-1918.
116. Oyoyo U.A., Shah U.S., Murray S.A. The role of alpha1 (connexin-43) gap junction expression in adrenal cortical cell function. Endocrinology 1997, 138:5385-5397.
117. Peebles K.A., Duncan M.W., Ruch R.J., Malkinson A.M. Proteomic analysis of a neoplastic mouse lung epithelial cell line whose tumorigenicity has been abrogated by transfection with the gap junction structural gene for connexin 43, Gja1. Carcinogenesis 2003, 24:651-657.
118. Princen F., Robe P., Gros D., Jarry-Guichard T., Gielen J., Merville M.P., Bours V. Rat gap junction connexin-30 inhibits proliferation of glioma cell lines. Carcinogenesis 2001, 22:507-513.
119. Prost G., Bernier-Valentin F., Munari-Silem Y., Selmi-Ruby S., Rousset B. Connexin-32 acts as a downregulator of growth of thyroid gland. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E291-E299.
120. Proulx A.A., Lin Z.X., Naus C.C. Transfection of rhabdomyosarcoma cells with connexin43 induces myogenic differentiation. Cell Growth Differ. 1997, 8:533-540.
121. Qin H., Shao Q., Curtis H., Galipeau J., Belliveau D.J., Wang T., Alaoui-Jamali M.A., Laird D.W. Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication. J. Biol. Chem. 2002, 277:29132-29138.
122. Qin H., Shao Q., Thomas T., Kalra J., Alaoui-Jamali M.A., Laird D.W. Connexin26 regulates the expression of angiogenesis-related genes in human breast tumor cells by both GJIC-dependent and -independent mechanisms. Cell Commun. Adhes. 2003, 10:387-393.
123. Rae R.S., Mehta P.P., Chang C.C., Trosko J.E., Ruch R.J. Neoplastic phenotype of gap-junctional intercellular communication-deficient WB rat liver epithelial cells and its reversal by forced expression of connexin 32. Mol. Carcinog. 1998, 22:120-127.
124. Roger C., Mograbi B., Chevallier D., Michiels J.F., Tanaka H., Segretain D., Pointis G., Fenichel P. Disrupted traffic of connexin 43 in human testicular seminoma cells: overexpression of Cx43 induces membrane location and cell proliferation decrease. J. Pathol. 2004, 202:241-246.
125. Ruch R.J., Guan X., Sigler K. Inhibition of gap junctional intercellular communication and enhancement of growth in BALB/c 3T3 cells treated with connexin43 antisense oligonucleotides. Mol. Carcinog. 1995, 14:269-274.
126. Sato H., Fukumoto K., Hada S., Hagiwara H., Fujimoto E., Negishi E., Ueno K., Yano T. Enhancing effect of connexin 32 gene on vinorelbine-induced cytotoxicity in A549 lung adenocarcinoma cells. Cancer Chemother. Pharmacol. 2007, 60:449-457.
127. Sato H., Hagiwara H., Ohde Y., Senba H., Virgona N., Yano T. Regulation of renal cell carcinoma cell proliferation, invasion and metastasis by connexin 32 gene. J. Membr. Biol. 2007, 216:17-21.
128. Sato H., Hagiwara H., Senba H., Fukumoto K., Nagashima Y., Yamasaki H., Ueno K., Yano T. The inhibitory effect of connexin 32 gene on metastasis in renal cell carcinoma. Mol. Carcinog. 2008, 47:403-409.
129. Sato H., Senba H., Virgona N., Fukumoto K., Ishida T., Hagiwara H., Negishi E., Ueno K., Yamasaki H., Yano T. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells. Mol. Carcinog. 2007, 46:215-224.
130. Shao Q., Wang H., McLachlan E., Veitch G.I., Laird D.W. Down-regulation of Cx43 by retroviral delivery of small interfering RNA promotes an aggressive breast cancer cell phenotype. Cancer Res. 2005, 65:2705-2711.
131. Shima K., Muramatsu T., Abiko Y., Yamaoka Y., Sasaki H., Shimono M. Connexin 43 transfection in basaloid squamous cell carcinoma cells. Oncol. Rep. 2006, 16:285-288.
132. Sridharan S., Simon L., Meling D.D., Cyr D.G., Gutstein D.E., Fishman G.I., Guillou F., Cooke P.S. Proliferation of adult sertoli cells following conditional knockout of the Gap junctional protein GJA1 (connexin 43) in mice. Biol. Reprod. 2007, 76:804-812.
133. Statuto M., Audebet C., Tonoli H., Selmi-Ruby S., Rousset B., Munari-Silem Y. Restoration of cell-to-cell communication in thyroid cell lines by transfection with and stable expression of the connexin-32 gene. Impact on cell proliferation and tissue-specific gene expression. J. Biol. Chem. 1997, 272:24710-24716.
134. Tanaka M., Grossman H.B. Connexin 26 induces growth suppression, apoptosis and increased efficacy of doxorubicin in prostate cancer cells. Oncol. Rep. 2004, 11:537-541.
135. Tanaka M., Grossman H.B. Connexin 26 gene therapy of human bladder cancer: induction of growth suppression, apoptosis, and synergy with Cisplatin. Hum. Gene Ther. 2001, 12:2225-2236.
136. Temme A., Buchmann A., Gabriel H.D., Nelles E., Schwarz M., Willecke K. High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32. Curr. Biol. 1997, 7:713-716.
137. Vozzi C., Bosco D., Dupont E., Charollais A., Meda P. Hyperinsulinemia-induced hypoglycemia is enhanced by overexpression of connexin 43. Endocrinology 1997, 138:2879-2885.
138. Yano T., Hernandez-Blazquez F.J., Omori Y., Yamasaki H. Reduction of malignant phenotype of HEPG2 cell is associated with the expression of connexin 26 but not connexin 32. Carcinogenesis 2001, 22:1593-1600.
139. Yano T., Yamasaki H. Regulation of cellular invasion and matrix metalloproteinase activity in HepG2 cell by connexin 26 transfection. Mol. Carcinog. 2001, 31:101-109.
140. Yoon B.I., Hirabayashi Y., Kawasaki Y., Tsuboi I., Ott T., Kodama Y., Kanno J., Kim D.Y., Willecke K., Inoue T. Exacerbation of benzene pneumotoxicity in connexin 32 knockout mice: enhanced proliferation of CYP2E1-immunoreactive alveolar epithelial cells. Toxicology 2004, 195:19-29.
141. Zhang Y., Kanter E.M., Laing J.G., Aprhys C., Johns D.C., Kardami E., Yamada K.A. Connexin43 expression levels influence intercellular coupling and cell proliferation of native murine cardiac fibroblasts. Cell Commun. Adhes. 2008, 15:289-303.
142. Zhang Y.W., Kaneda M., Morita I. The gap junction-independent tumor-suppressing effect of connexin 43. J. Biol. Chem. 2003, 278:44852-44856.
143. Zhang Y.W., Morita I., Ikeda M., Ma K.W., Murota S. Connexin43 suppresses proliferation of osteosarcoma U2OS cells through post-transcriptional regulation of p27. Oncogene 2001, 20:4138-4149.
144. Zhang Y.W., Nakayama K., Nakayama K., Morita I. A novel route for connexin 43 to inhibit cell proliferation: negative regulation of S-phase kinase-associated protein. Cancer Res. 2003, 63:1623-1630.
145. Zhang Z.Q., Zhang W., Wang N.Q., Bani-Yaghoub M., Lin Z.X., Naus C.C. Suppression of tumorigenicity of human lung carcinoma cells after transfection with connexin43. Carcinogenesis 1998, 19:1889-1894.
146. Zhu D., Caveney S., Kidder G.M., Naus C.C. Transfection of C6 glioma cells with connexin 43 cDNA: analysis of expression, intercellular coupling, and cell proliferation. Proc. Natl Acad. Sci. USA 1991, 88:1883-1887.
147. Zhu D., Kidder G.M., Caveney S., Naus C.C. Growth retardation in glioma cells cocultured with cells overexpressing a gap junction protein. Proc. Natl Acad. Sci. USA 1992, 89:10218-10221.
148. Johnstone S.R., Best A.K., Wright C.S., Isakson B.E., Errington R.J., Martin P.E. Enhanced connexin 43 expression delays intra-mitotic duration and cell cycle traverse independently of gap junction channel function. J. Cell. Biochem. 2010, 110:772-782.
149. Avanzo J.L., Mesnil M., Hernandez-Blazquez F.J., Mackowiak I.I., Mori C.M., da Silva T.C., Oloris S.C., Garate A.P., Massironi S.M., Dagli M.L. Increased susceptibility to urethane-induced lung tumors in mice with decreased expression of connexin43. Carcinogenesis 2004, 25:1973-1982.
150. Dagli M.L., Yamasaki H., Krutovskikh V., Omori Y. Delayed liver regeneration and increased susceptibility to chemical hepatocarcinogenesis in transgenic mice expressing a dominant-negative mutant of connexin32 only in the liver. Carcinogenesis 2004, 25:483-492.
151. Eghbali B., Kessler J.A., Reid L.M., Roy C., Spray D.C. Involvement of gap junctions in tumorigenesis: transfection of tumor cells with connexin 32 cDNA retards growth in vivo. Proc. Natl Acad. Sci. USA 1991, 88:10701-10705.
152. King T.J., Lampe P.D. Mice deficient for the gap junction protein Connexin32 exhibit increased radiation-induced tumorigenesis associated with elevated mitogen-activated protein kinase (p44/Erk1, p42/Erk2) activation. Carcinogenesis 2004, 25:669-680.
153. Luebeck E.G., Buchmann A., Schneider D., Moolgavkar S.H., Schwarz M. Modulation of liver tumorigenesis in Connexin32-deficient mouse. Mutat. Res. 2005, 570:33-47.
154. Burt J.M., Nelson T.K., Simon A.M., Fang J.S. Connexin 37 profoundly slows cell cycle progression in rat insulinoma cells. Am. J. Physiol. Cell Physiol. 2008, 295:C1103-C1112.
155. Flachon V., Tonoli H., Selmi-Ruby S., Durand C., Rabilloud R., Rousset B., Munari-Silem Y. Thyroid cell proliferation in response to forced expression of gap junction proteins. Eur. J. Cell Biol. 2002, 81:243-252.
156. Goldberg G.S., Bechberger J.F., Tajima Y., Merritt M., Omori Y., Gawinowicz M.A., Narayanan R., Tan Y., Sanai Y., Yamasaki H., Naus C.C., Tsuda H., Nicholson B.J. Connexin43 suppresses MFG-E8 while inducing contact growth inhibition of glioma cells. Cancer Res. 2000, 60:6018-6026.
157. Mesnil M., Krutovskikh V., Piccoli C., Elfgang C., Traub O., Willecke K., Yamasaki H. Negative growth control of HeLa cells by connexin genes: connexin species specificity. Cancer Res. 1995, 55:629-639.
158. Becker D.L., Mobbs P. Connexin alpha1 and cell proliferation in the developing chick retina. Exp. Neurol. 1999, 156:326-332.
159. Chadjichristos C.E., Matter C.M., Roth I., Sutter E., Pelli G., Luscher T.F., Chanson M., Kwak B.R. Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice. Circulation 2006, 113:2835-2843.
160. Freidin M., Asche S., Bargiello T.A., Bennett M.V., Abrams C.K. Connexin 32 increases the proliferative response of Schwann cells to neuregulin-1. Proc. Natl Acad. Sci. USA 2009, 106:3567-3572.
161. Hoptak-Solga A.D., Nielsen S., Jain I., Thummel R., Hyde D.R., Iovine M.K. Connexin43 (GJA1) is required in the population of dividing cells during fin regeneration. Dev. Biol. 2008, 317:541-548.
162. Lim M.C., Maubach G., Zhuo L. TGF-beta1 down-regulates connexin 43 expression and gap junction intercellular communication in rat hepatic stellate cells. Eur. J. Cell Biol. 2009, 88:719-730.
163. Naus C.C., Bechberger J.F., Zhang Y., Venance L., Yamasaki H., Juneja S.C., Kidder G.M., Giaume C. Altered gap junctional communication, intercellular signaling, and growth in cultured astrocytes deficient in connexin43. J. Neurosci. Res. 1997, 49:528-540.
164. Oloris S.C., Mesnil M., Reis V.N., Sakai M., Matsuzaki P., Fonseca Ede S., da Silva T.C., Avanzo J.L., Sinhorini I.L., Guerra J.L., Costa-Pinto F.A., Maiorka P.C., Dagli M.L. Hepatic granulomas induced by Schistosoma mansoni in mice deficient for connexin 43 present lower cell proliferation and higher collagen content. Life Sci. 2007, 80:1228-1235.
165. Ozawa H., Mutai H., Matsunaga T., Tokumaru Y., Fujii M., Sakamoto K., Tomita T., Ogawa K. Promoted cell proliferation by connexin 30 gene transfection to head-and-neck cancer cell line. Anticancer Res. 2009, 29:1981-1985.
166. Sellitto C., Li L., White T.W. Connexin50 is essential for normal postnatal lens cell proliferation. Invest. Ophthalmol Vis Sci. 2004, 45:3196-3202.
167. Song M., Yu X., Cui X., Zhu G., Zhao G., Chen J., Huang L. Blockade of connexin 43 hemichannels reduces neointima formation after vascular injury by inhibiting proliferation and phenotypic modulation of smooth muscle cells. Exp. Biol. Med. 2009, 234:1192-1200.
168. Theis M., Speidel D., Willecke K. Astrocyte cultures from conditional connexin43-deficient mice. Glia 2004, 46:130-141.
169. Wang H.H., Kung C.I., Tseng Y.Y., Lin Y.C., Chen C.H., Tsai C.H., Yeh H.I. Activation of endothelial cells to pathological status by down-regulation of connexin43. Cardiovasc. Res. 2008, 79:509-518.
170. Veitch G.I., Gittens J.E., Shao Q., Laird D.W., Kidder G.M. Selective assembly of connexin37 into heterocellular gap junctions at the oocyte/granulosa cell interface. J. Cell Sci. 2004, 117:2699-2707.
171. Ott T., Jokwitz M., Lenhard D., Romualdi A., Dombrowski F., Ittrich C., Schwarz M., Willecke K. Ablation of gap junctional communication in hepatocytes of transgenic mice does not lead to disrupted cellular homeostasis or increased spontaneous tumourigenesis. Eur. J. Cell Biol. 2006, 85:717-728.
172. Chipman J.K., Mally A., Edwards G.O. Disruption of gap junctions in toxicity and carcinogenicity. Toxicol. Sci. 2003, 71:146-153.
173. Kojima T., Fort A., Tao M., Yamamoto M., Spray D.C. Gap junction expression and cell proliferation in differentiating cultures of Cx43 KO mouse hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 281:G1004-G1013.
174. Yanagiya T., Tanabe A., Hotta K. Gap-junctional communication is required for mitotic clonal expansion during adipogenesis. Obesity 2007, 15:572-582.
175. Nishimura T., Dunk C., Lu Y., Feng X., Gellhaus A., Winterhager E., Rossant J., Lye S.J. Gap junctions are required for trophoblast proliferation in early human placental development. Placenta 2004, 25:595-607.
176. Kihara A.H., Santos T.O., Osuna-Melo E.J., Paschon V., Vidal K.S., Akamine P.S., Castro L.M., Resende R.R., Hamassaki D.E., Britto L.R. Connexin-mediated communication controls cell proliferation and is essential in retinal histogenesis. Int. J. Dev. Neurosci. 2010, 28:39-52.
177. Uyama N., Shimahara Y., Okuyama H., Kawada N., Kamo S., Ikeda K., Yamaoka Y. Carbenoxolone inhibits DNA synthesis and collagen gene expression in rat hepatic stellate cells in culture. J. Hepatol. 2003, 39:749-755.
178. Zhao W., Lin Z.X., Zhang Z.Q. Cisplatin-induced premature senescence with concomitant reduction of gap junctions in human fibroblasts. Cell Res. 2004, 14:60-66.
179. Gilleron J., Carette D., Durand P., Pointis G., Segretain D. Connexin 43 a potential regulator of cell proliferation and apoptosis within the seminiferous epithelium. Int. J. Biochem. Cell Biol. 2009, 41:1381-1390.
180. Ciovacco W.A., Goldberg C.G., Taylor A.F., Lemieux J.M., Horowitz M.C., Donahue H.J., Kacena M.A. The role of gap junctions in megakaryocyte-mediated osteoblast proliferation and differentiation. Bone 2009, 44:80-86.
181. Tabernero A., Sanchez-Alvarez R., Medina J.M. Increased levels of cyclins D1 and D3 after inhibition of gap junctional communication in astrocytes. J. Neurochem. 2006, 96:973-982.
182. Sela-Abramovich S., Edry I., Galiani D., Nevo N., Dekel N. Disruption of gap junctional communication within the ovarian follicle induces oocyte maturation. Endocrinology 2006, 147:2280-2286.
183. Tsutsumi M., Inoue K., Denda S., Ikeyama K., Goto M., Denda M. Mechanical-stimulation-evoked calcium waves in proliferating and differentiated human keratinocytes. Cell Tissue Res. 2009, 338:99-106.
184. Liu C.L., Huang Y.S., Hosokawa M., Miyashita K., Hu M.L. Inhibition of proliferation of a hepatoma cell line by fucoxanthin in relation to cell cycle arrest and enhanced gap junctional intercellular communication. Chem. Biol. Interact. 2009, 182:165-172.
185. Stork P.J., Schmitt J.M. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 2002, 12:258-266.
186. Norris R.P., Ratzan W.J., Freudzon M., Mehlmann L.M., Krall J., Movsesian M.A., Wang H., Ke H., Nikolaev V.O., Jaffe L.A. Cyclic GMP from the surrounding somatic cells regulates cyclic AMP and meiosis in the mouse oocyte. Development 2009, 136:1869-1878.
187. Vaccari S., Horner K., Mehlmann L.M., Conti M. Generation of mouse oocytes defective in cAMP synthesis and degradation: endogenous cyclic AMP is essential for meiotic arrest. Dev. Biol. 2008, 316:124-134.
188. Berridge M.J. Inositol trisphosphate and calcium signalling mechanisms. Biochim. Biophys. Acta 2009, 1793:933-940.
189. Stains J.P., Civitelli R. Gap junctions regulate extracellular signal-regulated kinase signaling to affect gene transcription. Mol. Biol. Cell 2005, 16:64-72.
190. Stains J.P., Civitelli R. Cell-to-cell interactions in bone. Biochem. Biophys. Res. Commun. 2005, 328:721-727.
191. Stains J.P., Lecanda F., Screen J., Towler D.A., Civitelli R. Gap junctional communication modulates gene transcription by altering the recruitment of Sp1 and Sp3 to connexin-response elements in osteoblast promoters. J. Biol. Chem. 2003, 278:24377-24387.
192. S. Pollok, A.C. Pfeiffer, R. Lobmann, C.S. Wright, I. Moll, P.E. Martin, J.M. Brandner, Connexin 43 mimetic peptide Gap27 reveals potential differences in the role of Cx43 in wound repair between diabetic and non-diabetic cells, J Cell Mol Med: (2010) doi:10.1111/j.1582-4934.2010.01057.x.
193. Belliveau D.J., Bani-Yaghoub M., McGirr B., Naus C.C., Rushlow W.J. Enhanced neurite outgrowth in PC12 cells mediated by connexin hemichannels and ATP. J. Biol. Chem. 2006, 281:20920-20931.
194. Essenfelder G.M., Bruzzone R., Lamartine J., Charollais A., Blanchet-Bardon C., Barbe M.T., Meda P., Waksman G. Connexin30 mutations responsible for hidrotic ectodermal dysplasia cause abnormal hemichannel activity. Hum. Mol. Genet. 2004, 13:1703-1714.
195. Weissman T.A., Riquelme P.A., Ivic L., Flint A.C., Kriegstein A.R. Calcium waves propagate through radial glial cells and modulate proliferation in the developing neocortex. Neuron 2004, 43:647-661.
196. Pearson R.A., Dale N., Llaudet E., Mobbs P. ATP released via gap junction hemichannels from the pigment epithelium regulates neural retinal progenitor proliferation. Neuron 2005, 46:731-744.
197. Pearson R.A., Luneborg N.L., Becker D.L., Mobbs P. Gap junctions modulate interkinetic nuclear movement in retinal progenitor cells. J. Neurosci. 2005, 25:10803-10814.
198. Liu X., Hashimoto-Torii K., Torii M., Ding C., Rakic P. Gap junctions/hemichannels modulate interkinetic nuclear migration in the forebrain precursors. J. Neurosci. 2010, 30:4197-4209.
199. Bennett M.V., Contreras J.E., Bukauskas F.F., Saez J.C. New roles for astrocytes: gap junction hemichannels have something to communicate. Trends Neurosci. 2003, 26:610-617.
200. De Flora A., Zocchi E., Guida L., Franco L., Bruzzone S. Autocrine and paracrine calcium signaling by the CD38/NAD+/cyclic ADP-ribose system. Ann. NY Acad. Sci. 2004, 1028:176-191.
201. Franco L., Zocchi E., Usai C., Guida L., Bruzzone S., Costa A., De Flora A. Paracrine roles of NAD+and cyclic ADP-ribose in increasing intracellular calcium and enhancing cell proliferation of 3T3 fibroblasts. J. Biol. Chem. 2001, 276:21642-21648.
202. Goodenough D.A., Paul D.L. Beyond the gap: functions of unpaired connexon channels. Nat. Rev. Mol. Cell Biol. 2003, 4:285-294.
203. Bruzzone S., Franco L., Guida L., Zocchi E., Contini P., Bisso A., Usai C., De Flora A. A self-restricted CD38-connexin 43 cross-talk affects NAD+and cyclic ADP-ribose metabolism and regulates intracellular calcium in 3T3 fibroblasts. J. Biol. Chem. 2001, 276:48300-48308.
204. Bier A., Oviedo-Landaverde I., Zhao J., Mamane Y., Kandouz M., Batist G. Connexin43 pseudogene in breast cancer cells offers a novel therapeutic target. Mol. Cancer Ther. 2009, 8:786-793.
205. Bond S.L., Bechberger J.F., Khoo N.K., Naus C.C. Transfection of C6 glioma cells with connexin32: the effects of expression of a nonendogenous gap junction protein. Cell Growth Differ. 1994, 5:179-186.
206. Dang X., Doble B.W., Kardami E. The carboxy-tail of connexin-43 localizes to the nucleus and inhibits cell growth. Mol. Cell. Biochem. 2003, 242:35-38.
207. Doble B.W., Dang X., Ping P., Fandrich R.R., Nickel B.E., Jin Y., Cattini P.A., Kardami E. Phosphorylation of serine 262 in the gap junction protein connexin-43 regulates DNA synthesis in cell-cell contact forming cardiomyocytes. J. Cell Sci. 2004, 117:507-514.
208. Duflot-Dancer A., Mesnil M., Yamasaki H. Dominant-negative abrogation of connexin-mediated cell growth control by mutant connexin genes. Oncogene 1997, 15:2151-2158.
209. Fujimoto E., Satoh H., Negishi E., Ueno K., Nagashima Y., Hagiwara K., Yamasaki H., Yano T. Negative growth control of renal cell carcinoma cell by connexin 32: possible involvement of Her-2. Mol. Carcinog. 2004, 40:135-142.
210. Huang R.P., Fan Y., Hossain M.Z., Peng A., Zeng Z.L., Boynton A.L. Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43. Cancer Res. 1998, 58:5089-5096.
211. Ionta M., Ferreira R.A., Pfister S.C., Machado-Santelli G.M. Exogenous Cx43 expression decrease cell proliferation rate in rat hepatocarcinoma cells independently of functional gap junction. Cancer Cell Int. 2009, 9:22.
212. Kalra J., Shao Q., Qin H., Thomas T., Alaoui-Jamali M.A., Laird D.W. Cx26 inhibits breast MDA-MB-435 cell tumorigenic properties by a gap junctional intercellular communication-independent mechanism. Carcinogenesis 2006, 27:2528-2537.
213. Kandouz M., Bier A., Carystinos G.D., Alaoui-Jamali M.A., Batist G. Connexin43 pseudogene is expressed in tumor cells and inhibits growth. Oncogene 2004, 23:4763-4770.
214. Krutovskikh V.A., Troyanovsky S.M., Piccoli C., Tsuda H., Asamoto M., Yamasaki H. Differential effect of subcellular localization of communication impairing gap junction protein connexin43 on tumor cell growth in vivo. Oncogene 2000, 19:505-513.
215. Moorby C., Patel M. Dual functions for connexins: Cx43 regulates growth independently of gap junction formation. Exp. Cell Res. 2001, 271:238-248.
216. Chen S.C., Pelletier D.B., Ao P., Boynton A.L. Connexin43 reverses the phenotype of transformed cells and alters their expression of cyclin/cyclin-dependent kinases. Cell Growth Differ. 1995, 6:681-690.
217. Fujimoto E., Sato H., Nagashima Y., Negishi E., Shirai S., Fukumoto K., Hagiwara H., Hagiwara K., Ueno K., Yano T. A Src family inhibitor (PP1) potentiates tumor-suppressive effect of connexin 32 gene in renal cancer cells. Life Sci. 2005, 76:2711-2720.
218. King T.J., Gurley K.E., Prunty J., Shin J.L., Kemp C.J., Lampe P.D. Deficiency in the gap junction protein connexin32 alters p27Kip1 tumor suppression and MAPK activation in a tissue-specific manner. Oncogene 2005, 24:1718-1726.
219. King T.J., Lampe P.D. Altered tumor biology and tumorigenesis in irradiated and chemical carcinogen-treated single and combined connexin32/p27Kip1-deficient mice. Cell Commun. Adhes. 2005, 12:293-305.
220. Koffler L., Roshong S., Kyu Park I., Cesen-Cummings K., Thompson D.C., Dwyer-Nield L.D., Rice P., Mamay C., Malkinson A.M., Ruch R.J. Growth inhibition in G(1) and altered expression of cyclin D1 and p27(kip-1)after forced connexin expression in lung and liver carcinoma cells. J. Cell. Biochem. 2000, 79:347-354.
221. Matsuyama D., Kawahara K. Proliferation of neonatal cardiomyocytes by connexin43 knockdown via synergistic inactivation of p38 MAPK and increased expression of FGF1. Basic Res. Cardiol. 2009, 104:631-642.
222. Huang R., Lin Y., Wang C.C., Gano J., Lin B., Shi Q., Boynton A., Burke J., Huang R.P. Connexin 43 suppresses human glioblastoma cell growth by down-regulation of monocyte chemotactic protein 1, as discovered using protein array technology. Cancer Res. 2002, 62:2806-2812.
223. Li X., Xu Y.B., Wang Q., Lu Y., Zheng Y., Wang Y.C., Lubbert M., Zhao K.W., Chen G.Q. Leukemogenic AML1-ETO fusion protein upregulates expression of connexin 43: the role in AML 1-ETO-induced growth arrest in leukemic cells. J. Cell. Physiol. 2006, 208:594-601.
224. Akiyama T. Wnt/beta-catenin signaling. Cytokine Growth Factor Rev. 2000, 11:273-282.
225. Giles R.H., van Es J.H., Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 2003, 1653:1-24.
226. MacDonald B.T., Tamai K., He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 2009, 17:9-26.
227. Sharpe C., Lawrence N., Martinez Arias A. Wnt signalling: a theme with nuclear variations. Bioessays 2001, 23:311-318.
228. Zhai Y., Wu R., Schwartz D.R., Darrah D., Reed H., Kolligs F.T., Nieman M.T., Fearon E.R., Cho K.R. Role of beta-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas. Am. J. Pathol. 2002, 160:1229-1238.
229. Davidson G., Shen J., Huang Y.L., Su Y., Karaulanov E., Bartscherer K., Hassler C., Stannek P., Boutros M., Niehrs C. Cell cycle control of wnt receptor activation. Dev. Cell 2009, 17:788-799.
230. Ai Z., Fischer A., Spray D.C., Brown A.M., Fishman G.I. Wnt-1 regulation of connexin43 in cardiac myocytes. J. Clin. Invest. 2000, 105:161-171.
231. Kamei J., Toyofuku T., Hori M. Negative regulation of p21 by beta-catenin/TCF signaling: a novel mechanism by which cell adhesion molecules regulate cell proliferation. Biochem. Biophys. Res. Commun. 2003, 312:380-387.
232. van der Heyden M.A., Rook M.B., Hermans M.M., Rijksen G., Boonstra J., Defize L.H., Destree O.H. Identification of connexin43 as a functional target for Wnt signalling. J. Cell Sci. 1998, 111:1741-1749.
233. Constantinou T., Baumann F., Lacher M.D., Saurer S., Friis R., Dharmarajan A. SFRP-4 abrogates Wnt-3a-induced beta-catenin and Akt/PKB signalling and reverses a Wnt-3a-imposed inhibition of in vitro mammary differentiation. J. Mol. Signaling 2008, 3:10.
234. Czyz J., Guan K., Zeng Q., Wobus A.M. Loss of beta 1 integrin function results in upregulation of connexin expression in embryonic stem cell-derived cardiomyocytes. Int. J. Dev. Biol. 2005, 49:33-41.
235. Du W.J., Li J.K., Wang Q.Y., Hou J.B., Yu B. Lithium chloride regulates connexin43 in skeletal myoblasts in vitro: possible involvement in Wnt/beta-catenin signaling. Cell Commun. Adhes. 2008, 15:261-271.
236. Kuwabara M., Kakinuma Y., Katare R.G., Ando M., Yamasaki F., Doi Y., Sato T. Granulocyte colony-stimulating factor activates Wnt signal to sustain gap junction function through recruitment of beta-catenin and cadherin. FEBS Lett. 2007, 581:4821-4830.
237. Liu X., Liu W., Yang L., Xia B., Li J., Zuo J., Li X. Increased connexin 43 expression improves the migratory and proliferative ability of H9c2 cells by Wnt-3a overexpression. Acta Biochim. Biophys. Sin. 2007, 39:391-398.
238. Meyer R.A., Cohen M.F., Recalde S., Zakany J., Bell S.M., Scott W.J., Lo C.W. Developmental regulation and asymmetric expression of the gene encoding Cx43 gap junctions in the mouse limb bud. Dev. Genet. 1997, 21:290-300.
239. Robinson J.A., Chatterjee-Kishore M., Yaworsky P.J., Cullen D.M., Zhao W., Li C., Kharode Y., Sauter L., Babij P., Brown E.L., Hill A.A., Akhter M.P., Johnson M.L., Recker R.R., Komm B.S., Bex F.J. Wnt/beta-catenin signaling is a normal physiological response to mechanical loading in bone. J. Biol. Chem. 2006, 281:31720-31728.
240. Samarzija I., Sini P., Schlange T., Macdonald G., Hynes N.E. Wnt3a regulates proliferation and migration of HUVEC via canonical and non-canonical Wnt signaling pathways. Biochem. Biophys. Res. Commun. 2009, 386:449-454.
241. Santos A., Bakker A.D., Zandieh-Doulabi B., Semeins C.M., Klein-Nulend J. Pulsating fluid flow modulates gene expression of proteins involved in Wnt signaling pathways in osteocytes. J. Orthop. Res. 2009, 27:1280-1287.
242. Du W.J., Li J.K., Wang Q.Y., Hou J.B., Yu B. Lithium chloride preconditioning optimizes skeletal myoblast functions for cellular cardiomyoplasty in vitro via glycogen synthase kinase-3beta/beta-catenin signaling. Cells Tissues Organs 2009, 190:11-19.
243. Duffy H.S., Delmar M., Spray D.C. Formation of the gap junction nexus: binding partners for connexins. J. Physiol. Paris 2002, 96:243-249.
244. Giepmans B.N. Gap junctions and connexin-interacting proteins. Cardiovasc. Res. 2004, 62:233-245.
245. Nambara C., Kawasaki Y., Yamasaki H. Role of the cytoplasmic loop domain of Cx43 in its intracellular localization and function: possible interaction with cadherin. J. Membr. Biol. 2007, 217:63-69.
246. Thomas M.A., Huang S., Cokoja A., Riccio O., Staub O., Suter S., Chanson M. Interaction of connexins with protein partners in the control of channel turnover and gating. Biol. Cell 2002, 94:445-456.
247. Chakraborty S., Mitra S., Falk M.M., Caplan S.H., Wheelock M.J., Johnson K.R., Mehta P.P. E-cadherin differentially regulates the assembly of Connexin43 and Connexin32 into gap junctions in human squamous carcinoma cells. J. Biol. Chem. 2010, 285:10761-10776.
248. Hernandez-Blazquez F.J., Joazeiro P.P., Omori Y., Yamasaki H. Control of intracellular movement of connexins by E-cadherin in murine skin papilloma cells. Exp. Cell Res. 2001, 270:235-247.
249. Hsu M., Andl T., Li G., Meinkoth J.L., Herlyn M. Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. J. Cell Sci. 2000, 113:1535-1542.
250. Jongen W.M., Fitzgerald D.J., Asamoto M., Piccoli C., Slaga T.J., Gros D., Takeichi M., Yamasaki H. Regulation of connexin 43-mediated gap junctional intercellular communication by Ca2+ in mouse epidermal cells is controlled by E-cadherin. J. Cell Biol. 1991, 114:545-555.
251. Li J., Patel V.V., Kostetskii I., Xiong Y., Chu A.F., Jacobson J.T., Yu C., Morley G.E., Molkentin J.D., Radice G.L. Cardiac-specific loss of N-cadherin leads to alteration in connexins with conduction slowing and arrhythmogenesis. Circ. Res. 2005, 97:474-481.
252. Matsuda T., Fujio Y., Nariai T., Ito T., Yamane M., Takatani T., Takahashi K., Azuma J. N-cadherin signals through Rac1 determine the localization of connexin 43 in cardiac myocytes. J. Mol. Cell. Cardiol. 2006, 40:495-502.
253. Meyer R.A., Laird D.W., Revel J.P., Johnson R.G. Inhibition of gap junction and adherens junction assembly by connexin and A-CAM antibodies. J. Cell Biol. 1992, 119:179-189.
254. Nishimura M., Saito T., Yamasaki H., Kudo R. Suppression of gap junctional intercellular communication via 5' CpG island methylation in promoter region of E-cadherin gene in endometrial cancer cells. Carcinogenesis 2003, 24:1615-1623.
255. Prowse D.M., Cadwallader G.P., Pitts J.D. E-cadherin expression can alter the specificity of gap junction formation. Cell Biol. Int. 1997, 21:833-843.
256. Wei C.J., Francis R., Xu X., Lo C.W. Connexin43 associated with an N-cadherin-containing multiprotein complex is required for gap junction formation in NIH3T3 cells. J. Biol. Chem. 2005, 280:19925-19936.
257. Fujimoto K., Nagafuchi A., Tsukita S., Kuraoka A., Ohokuma A., Shibata Y. Dynamics of connexins, E-cadherin and alpha-catenin on cell membranes during gap junction formation. J Cell Sci 1997, 110:311-322.
258. Xu H.T., Li Q.C., Zhang Y.X., Zhao Y., Liu Y., Yang Z.Q., Wang E.H. Connexin 43 recruits E-cadherin expression and inhibits the malignant behaviour of lung cancer cells. Folia Histochem. Cytobiol. 2008, 46:315-321.
259. Gupta N., Wang H., McLeod T.L., Naus C.C., Kyurkchiev S., Advani S., Yu J., Perbal B., Weichselbaum R.R. Inhibition of glioma cell growth and tumorigenic potential by CCN3. Mol. Pathol. 2001, 54:293-299.
260. McLeod T.L., Bechberger J.F., Naus C.C. Determination of a potential role of the CCN family of growth regulators in connexin43 transfected C6 glioma cells. Cell Commun. Adhes. 2001, 8:441-445.
261. Naus C.C., Bond S.L., Bechberger J.F., Rushlow W. Identification of genes differentially expressed in C6 glioma cells transfected with connexin43. Brain Res. Brain Res. Rev. 2000, 32:259-266.
262. Sin W.C., Bechberger J.F., Rushlow W.J., Naus C.C. Dose-dependent differential upregulation of CCN1/Cyr61 and CCN3/NOV by the gap junction protein Connexin43 in glioma cells. J. Cell. Biochem. 2008, 103:1772-1782.
263. Fu C.T., Bechberger J.F., Ozog M.A., Perbal B., Naus C.C. CCN3 (NOV) interacts with connexin43 in C6 glioma cells: possible mechanism of connexin-mediated growth suppression. J. Biol. Chem. 2004, 279:36943-36950.
264. Gellhaus A., Dong X., Propson S., Maass K., Klein-Hitpass L., Kibschull M., Traub O., Willecke K., Perbal B., Lye S.J., Winterhager E. Connexin43 interacts with NOV: a possible mechanism for negative regulation of cell growth in choriocarcinoma cells. J. Biol. Chem. 2004, 279:36931-36942.
265. Gellhaus A., Wotzlaw C., Otto T., Fandrey J., Winterhager E. More insights into the CCN3/Connexin43 interaction complex and its role for signaling. J. Cell. Biochem. 2010, 110:129-140.
266. Chen C.C., Lau L.F. Functions and mechanisms of action of CCN matricellular proteins. Int. J. Biochem. Cell Biol. 2009, 41:771-783.
267. Li X., Penes M., Odermatt B., Willecke K., Nagy J.I. Ablation of Cx47 in transgenic mice leads to the loss of MUPP1, ZONAB and multiple connexins at oligodendrocyte-astrocyte gap junctions. Eur. J. Neurosci. 2008, 28:1503-1517.
268. Penes M.C., Li X., Nagy J.I. Expression of zonula occludens-1 (ZO-1) and the transcription factor ZO-1-associated nucleic acid-binding protein (ZONAB)-MsY3 in glial cells and colocalization at oligodendrocyte and astrocyte gap junctions in mouse brain. Eur. J. Neurosci. 2005, 22:404-418.
269. Sourisseau T., Georgiadis A., Tsapara A., Ali R.R., Pestell R., Matter K., Balda M.S. Regulation of PCNA and cyclin D1 expression and epithelial morphogenesis by the ZO-1-regulated transcription factor ZONAB/DbpA. Mol. Cell. Biol. 2006, 26:2387-2398.
270. Balda M.S., Garrett M.D., Matter K. The ZO-1-associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density. J. Cell Biol. 2003, 160:423-432.
271. Matter K., Balda M.S. Signalling to and from tight junctions. Nat. Rev. Mol. Cell Biol. 2003, 4:225-236.
272. Frankel P., Aronheim A., Kavanagh E., Balda M.S., Matter K., Bunney T.D., Marshall C.J. RalA interacts with ZONAB in a cell density-dependent manner and regulates its transcriptional activity. EMBO J. 2005, 24:54-62.
273. Tsapara A., Matter K., Balda M.S. The heat-shock protein Apg-2 binds to the tight junction protein ZO-1 and regulates transcriptional activity of ZONAB. Mol. Biol. Cell 2006, 17:1322-1330.
274. Buchert M., Darido C., Lagerqvist E., Sedello A., Cazevieille C., Buchholz F., Bourgaux J.F., Pannequin J., Joubert D., Hollande F. The symplekin/ZONAB complex inhibits intestinal cell differentiation by the repression of AML1/Runx1. Gastroenterology 2009, 137:156-164.
275. Kavanagh E., Buchert M., Tsapara A., Choquet A., Balda M.S., Hollande F., Matter K. Functional interaction between the ZO-1-interacting transcription factor ZONAB/DbpA and the RNA processing factor symplekin. J. Cell Sci. 2006, 119:5098-5105.
276. Nie M., Aijaz S., Leefa Chong San I.V., Balda M.S., Matter K. The Y-box factor ZONAB/DbpA associates with GEF-H1/Lfc and mediates Rho-stimulated transcription. EMBO Rep. 2009, 10:1125-1131.
277. Singh D., Solan J.L., Taffet S.M., Javier R., Lampe P.D. Connexin 43 interacts with zona occludens-1 and -2 proteins in a cell cycle stage-specific manner. J. Biol. Chem. 2005, 280:30416-30421.
278. Betanzos A., Huerta M., Lopez-Bayghen E., Azuara E., Amerena J., Gonzalez-Mariscal L. The tight junction protein ZO-2 associates with Jun, Fos and C/EBP transcription factors in epithelial cells. Exp Cell Res 2004, 292:51-66.
279. Islas S., Vega J., Ponce L., Gonzalez-Mariscal L. Nuclear localization of the tight junction protein ZO-2 in epithelial cells. Exp. Cell Res. 2002, 274:138-148.
280. Jaramillo B.E., Ponce A., Moreno J., Betanzos A., Huerta M., Lopez-Bayghen E., Gonzalez-Mariscal L. Characterization of the tight junction protein ZO-2 localized at the nucleus of epithelial cells. Exp. Cell Res. 2004, 297:247-258.
281. Tapia R., Huerta M., Islas S., Avila-Flores A., Lopez-Bayghen E., Weiske J., Huber O., Gonzalez-Mariscal L. Zona occludens-2 inhibits cyclin D1 expression and cell proliferation and exhibits changes in localization along the cell cycle. Mol. Biol. Cell 2009, 20:1102-1117.
282. Huerta M., Munoz R., Tapia R., Soto-Reyes E., Ramirez L., Recillas-Targa F., Gonzalez-Mariscal L., Lopez-Bayghen E. Cyclin D1 is transcriptionally down-regulated by ZO-2 via an E box and the transcription factor c-Myc. Mol. Biol. Cell 2007, 18:4826-4836.
283. Duffy H.S., Iacobas I., Hotchkiss K., Hirst-Jensen B.J., Bosco A., Dandachi N., Dermietzel R., Sorgen P.L., Spray D.C. The gap junction protein connexin32 interacts with the Src homology 3/hook domain of discs large homolog 1. J. Biol. Chem. 2007, 282:9789-9796.
284. MacVicar B.A., Thompson R.J. Non-junction functions of pannexin-1 channels. Trends Neurosci. 2010, 33:93-102.
285. Shestopalov V.I., Panchin Y. Pannexins and gap junction protein diversity. Cell. Mol. Life Sci. 2008, 65:376-394.
286. Lai C.P., Bechberger J.F., Thompson R.J., MacVicar B.A., Bruzzone R., Naus C.C. Tumor-suppressive effects of pannexin 1 in C6 glioma cells. Cancer Res. 2007, 67:1545-1554.
287. Lai C.P., Bechberger J.F., Naus C.C. Pannexin2 as a novel growth regulator in C6 glioma cells. Oncogene 2009, 28:4402-4408.
288. Schenk U., Westendorf A.M., Radaelli E., Casati A., Ferro M., Fumagalli M., Verderio C., Buer J., Scanziani E., Grassi F. Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Sci. Signal. 2008, 1:ra6.
289. Nishida M., Sato Y., Uemura A., Narita Y., Tozaki-Saitoh H., Nakaya M., Ide T., Suzuki K., Inoue K., Nagao T., Kurose H. P2Y6 receptor-Galpha12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis. EMBO J. 2008, 27:3104-3115.
290. Iwamoto T., Nakamura T., Doyle A., Ishikawa M., de Vega S., Fukumoto S., Yamada Y. Pannexin 3 regulates intracellular ATP/cAMP levels and promotes chondrocyte differentiation. J. Biol. Chem. 2010, 285:18948-18958.
291. Locke D., Bian S., Li H., Harris A.L. Post-translational modifications of connexin26 revealed by mass spectrometry. Biochem. J. 2009, 424:385-398.
292. Penuela S., Bhalla R., Gong X.Q., Cowan K.N., Celetti S.J., Cowan B.J., Bai D., Shao Q., Laird D.W. Pannexin 1 and pannexin 3 are glycoproteins that exhibit many distinct characteristics from the connexin family of gap junction proteins. J. Cell Sci. 2007, 120:3772-3783.
293. Penuela S., Bhalla R., Nag K., Laird D.W. Glycosylation regulates pannexin intermixing and cellular localization. Mol. Biol. Cell 2009, 20:4313-4323.
294. Spray D.C., Ye Z.C., Ransom B.R. Functional connexin "hemichannels": a critical appraisal. Glia 2006, 54:758-773.
295. Leybaert L., Braet K., Vandamme W., Cabooter L., Martin P.E., Evans W.H. Connexin channels, connexin mimetic peptides and ATP release. Cell Commun. Adhes. 2003, 10:251-257.